DelveInsight Business Research, LLP: Chronic Lower Back Pain Market to Showcase Tremendous Growth by 2032, Predicts DelveInsight | Key Companies to Look Out – Eli Lilly, Camurus, Braeburn Inc., Scilex Holding, Mesoblast Limited, AnGes MG

Thursday, 21 September 2023, 23:06:00
The increase in the chronic lower back pain market size is a direct consequence of the expected launch of potential therapies, along with great competition among various companies and precision ap…
— Finanz Nachrichten

Obesity drugs by Novo Nordisk and Eli Lilly to impact healthcare economy

Thursday, 21 September 2023, 09:27:13
https://www.investing.com/news/stock-market-news/obesity-drugs-by-novo-nordisk-and-eli-lilly-to-impact-healthcare-economy-93CH-3179145
— Investing.com

Eli Lilly’s Mounjaro to become leading GLP-1 therapy for type 2 diabetes in NHS in UK: GlobalData

Thursday, 21 September 2023, 06:34:22
The National Institute for Health and Care Excellence (NICE) provided guidance in August 2023 explaining that where triple therapy with metformin and two other oral antidiabetic drugs has proven ineffective, the patients are eligible to change to GLP-1 therapies The post Eli Lilly’s Mounjaro to become leading GLP-1 therapy for type 2 diabetes in NHS in UK: GlobalData appeared first on Express Pharma .
— Express Pharma

Eli Lilly: Don”t Be Fooled By Greed

Wednesday, 20 September 2023, 18:30:00
Eli Lilly stock outperformed my previous expectations due to its solid execution and growth. Find out why investors must not fall prey to chasing LLY now.
— Seeking Alpha

Eli Lilly Sues Businesses Over Alleged Sales of Fake Mounjaro Diabetes Drugs

Wednesday, 20 September 2023, 17:36:22
Eli Lilly sued 10 medical spas, wellness centers, and compounding pharmacies across the U.S. for allegedly selling fraudulent products claiming to be its popular diabetes drug, Mounjaro.
— Investopedia